FdaApplication

ANDA 215796

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRICONPHARMA LLC
application_typeANDA
approval_date2024-11-22

Products (3)

ProductActive ingredientStrengthDosage form
OXCARBAZEPINEOXCARBAZEPINE600MGTABLET, EXTENDED RELEASE;ORAL
OXCARBAZEPINEOXCARBAZEPINE150MGTABLET, EXTENDED RELEASE;ORAL
OXCARBAZEPINEOXCARBAZEPINE300MGTABLET, EXTENDED RELEASE;ORAL

3 products